Caribou Biosciences, Inc.CRBUNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank17
3Y CAGR-16.7%
5Y CAGR-16.2%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-16.7%/yr
Annual compound
5Y CAGR
-16.2%/yr
Consistent
Percentile
P17
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 14.64 | -4.9% |
| 2024 | 15.39 | +33.0% |
| 2023 | 11.57 | -54.4% |
| 2022 | 25.36 | -63.6% |
| 2021 | 69.72 | +97.2% |
| 2020 | 35.35 | -50.2% |
| 2019 | 70.98 | - |